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Abstract 
 
Hypertension in patients with type 2 diabetes mellitus is a prevalent 
condition that leads to substantial morbidity and mortality. The aim of the study 
was to determine the prevalence of hypertension in type 2 diabetes attending 
endocrinology clinics at Hospital Universiti Sains Malaysia (HUSM), to describe 
antihypertensive treatment patterns, and to evaluate the target of blood 
pressure achieved by antihypertensive agents. The study was a prospective 
follow-up descriptive study. Study conducted at diabetic clinic outpatient at 
HUSM, Kelantan, Malaysia from January to December 2007. A total of 1077 
diabetic patients involve in this study. The findings of our study showed that the 
majority patients type 2 diabetes mellitus 998 (92.7 %) had hypertension.  For 
the patients who were on antihypertensive medications, 254 (23.6 %) of them 
were on monotherapy and 311 (28.9 %), 179 (16.6 %), and 198 (18.4 %) 
respectively received two, three and more than three antihypertensive agents. 
The majority of patients    872 (87.4 %) were on angiotensin converting enzyme 
inhibitors/angiotensin receptor blockers either alone or in combination with other 
antihypertensive drugs.  A number of 601 (55.8 %) patients achieved blood 
pressure targets ≤ 130/80 mm Hg.  Almost all patients with hypertension and 
diabetes will require a combination of antihypertensive medications. A number of 
patients was not   achieved blood pressure goals ≤ 130/80 mm Hg. There is still  
need to educate both patients and health care providers of importance of 
achieving target of blood pressure in order to reduce morbidity and mortality in 
diabetes mellitus patients. 
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Abstrak 
 
Penyakit hipertensi pada pasien diabetes mellitus tipe 2 merupakan   
penyebab utama mortalitas dan morbiditas. Penelitian bertujuan mengetahui 
prevalensi hipertensi pada pasien diabetes mellitus tipe 2 di klinik endokrinologi, 
Hospital Universiti Sains Malaysia (HUSM), gambaran pola antihipertensi,              
dan mengevaluasi target tekanan darah yang dapat dicapai dengan 
antihipertensi. Penelitian ini bersifat deskriptif dengan pengambilan data secara                
prospektif. Penelitian dilakukan pada klinik diabetes rawat jalan di HUSM,                  
Kelantan, Malaysia dari Januari hingga Desember 2007. Sejumlah 1077            
pasien diabetes masuk dalam penelitian ini. Hasil penelitian menunjukkan 
mayoritas  pasien  diabetes  mellitus  tipe 2  menderita  hipetensi 998 (92,7 %).                        
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Dari pasien yang menggunakan antihipertensi sejumlah 254 (23,6 %)              
pasien menggunakan monoterapi dan sejumlah 311 (28,9 %), 179 (16,6 %),                 
dan   198  (18,4 %)   menerima   dua,   tiga   dan  lebih dari tiga antihipertensi.  
Sebagian besar pasien  872 (87,4 %) menerima  angiotensin converting enzyme 
inhibitors/angiotensin receptor blockers  baik sebagai obat tunggal maupun 
dalam kombinasi dengan obat antihipertensi lain. Sejumlah  601 (55,8 %)  
pasien mencapai target tekanan darah ≤ 130/80 mm Hg. Hampir semua pasien 
hipertensi dan diabetes menggunakan kombinasi antihipertensi. Sejumlah 
pasien masih belum dapat mencapai target tekanan darah ≤ 130/80 mm Hg. 
Masih diperlukan edukasi baik kepada pasien maupun tenaga kesehatan akan 
pentingnya pencapaian target tekanan darah pada pasien diabetes sehingga  
dapat menurunkan morbiditas dan mortalitas.  
Kata kunci : hipertensi, diabetes mellitus tipe 2,  pengobatan hipertensi  
 
Introduction 
Type 2 diabetes mellitus (DM) is one           
of the world’s largest human health problems          
and a common disease with substantial 
associated morbidity and mortality (Amos et al., 
1997). Most adverse diabetes outcomes              
are a  result of vascular complications, both at a 
macrovascular level and a microvascular           
level. Experimental studies have not              
clearly shown relationship between improved 
glycaemic control and reductions in 
cardiovascular outcomes (Rosenbloom et al., 
1999).  It would seem more logical to               
focus diabetes care on prevention of 
macrovascular complications through              
blood pressure control  (Zimmet, 1995). 
Patients with diabetes have a much 
higher rate of hypertension than would              
be expected in the general population.               
In Malaysia, about 10.7 % patients with 
diabetes mellitus are associated with 
hypertension (Ministry of Health of              
Malaysia, 2002).  The co-existence of              
diabetes and hypertension in the patient is 
devastating to the cardiovascular system 
(Grossman and Messerli, 1996; Grossman et al., 
2000). Pharmacological treatment should                
be initiated in patients with diabetes when             
the blood pressure (BP) is persistently               
more than 130 mm Hg systolic and/or              
more than 80 mm Hg diastolic (World            
Health Organization, 1999; Schrier et al., 2002; 
American Diabetes Association, 2002).            
Barring contraindications, angiotensin 
converting enzyme inhibitors (ACEIs) and 
angiotensin  II  receptor  blockers  (ARBs)   are  
 
considered   first-line   therapy  in patients  
with diabetes and hypertension (Amos et 
al.,1997; Zimmet,1995).   
Research goal was to determine               
the prevalence of hypertension in type 2 
diabetes  mellitus, to describe antihyper- 
tensive treatment patterns, and to evaluate           
the target of BP achieved by antihypertensive 
agents.   
   
Methodology 
The study was a prospective follow-up 
descriptive study. Study conducted  during January 
to December 2007 in diabetic clinic outpatients at 
HUSM, Kelantan, Malaysia.  A total of 1077 type 2 
DM patients attending into diabetic clinic involve in 
this study.  These patients had been diagnosed            
and were on treatment for DM for at least                   
12 months. Patients who were juvenile diabetes, 
gestational diabetes, advanced chronic kidney 
disease and diabetes due to other causes were 
excluded.  
Data collection was conducted through 
patient’s medical record. Data included 
demographical characteristics, duration of having 
diabetes mellitus, blood pressure measurement, and 
type of antihypertensive drugs used. 
The standard mercury sphygmo-manometer 
(Accoson Works, London, England) was used with 
an appropriately-sized cuff on the right arm of the 
patient who was adequately rested for at least five 
minutes and seated with the arm supported at 
his/her heart level. In this study, hypertension was 
taken as systolic blood pressure (SBP) of 130 mm 
Hg or greater and/or diastolic blood pressure 
(DBP) of 80 mm Hg or greater, or they taking of 
antihypertensive medication (Ministry of Health of 
Malaysia, 2002). The patients had an average of at 
least two readings taken two minutes apart.  
Salwa Selim Ibrahim 
Majalah Farmasi Indonesia, 21(2), 2010 123
Initial elevated    blood   pressure   readings   
would   be confirmed on at least two subsequent 
visits over one week or more.  
Statistical Package for the Social Sciences 
(SPSS) software version 11.0 (Chicago, IL, USA) 
was used for data analysis.  
 
Results and Discussion 
There were 1077 patients with              
type 2 DM were enrolled in this                   
study. Descriptive statistics were used                     
to  describe  the  sample  as  shown  in Table I.   
 
 About   476 (44.2 %)  of  patients in this study 
were male. According  to racial distribution, 
916 (85.1 %) were Malay, another 161 (14.9 %) 
were Chinese and Indian. This proportion of 
ethnic group is generally reprehensible of the 
Kelantan state population.  
 The age of patients in this study range 
was from18 to 88 years and had been 
categorized into four groups.  Most patients in 
this study 626 (58.1 %)   were the age between 
51-65 years.   
Table I.  Demographic Characteristics of patients in study 
 
Variable  Frequency (%)  n=1077 
Gender                                                                                                 
Male                                                
Female                         
 
476 (44.2) 
601(55.8) 
Age (years)  
≤35 
36-50 
51-65 
>65 
 
15(1.4) 
194(18) 
626(58.1) 
242(22.5) 
Race 
Malay 
Chinese 
Indian 
 
916(85.1) 
150(13.9) 
11(1.0) 
BMI(kg/m2) 
 A target  < 23 kg/m2 for asia pacific 
 Non target  > 23 kg/m2 
 
199(18.5 %) 
878(81.5 %) 
Smoking History 
current smoker   
pervious smoker   
never smoked  
 
66(6.1) 
81 (7.5) 
930(86.4) 
Physical activity 
active > 150 min/wk 
non active < 150 min/wk   
 
471(43.7) 
606(56.3) 
Sistolic blood pressure (mmHg) 
<120   
120-139   
140-159 
> 159 
 
332 (30.8) 
289 (26.8) 
296 (27.5) 
160 (14.9) 
Diastolic  blood pressure (mmHg) 
<80   
80-89   
90-99 
> 100 
 
753 (69.9) 
33 (3.1) 
213 (19.8) 
78 (7.2) 
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Diabetes mellitus is mainly diagnosed in 
adults over 40 years of age, although 
increasingly, it is being found to have 
developed in younger people, including 
children (Rosenbloom et al.,1999). 
Growing prevalence of diabetes mellitus 
is now being strongly associated with a longer 
life expectancy, a more sedentary lifestyle       
and a greater tendency towards obesity 
(Zimmet,1995).  More than half of patients 606 
(56.3 %) in  our study had sedentary lifestyle 
(physical activity less 150 minute/week) and a 
greater tendency towards obesity 878 (81.5 %)  
with body mass index (BMI) more than                 
23 kg/m2.   
This study was classified  blood pressure 
according to Seventh Report of Joint National 
Committee on Prevention, Detection, 
Evaluation of Hypertension (JNC 7). The 
prevalence of hypertension in patients with 
diabetes in diabetic clinic HUSM was 998    
(92.7 %), which was comparable to studies 
elsewhere between 20 % until 60 %. (Arauz-
Pacheco et al., 2003). 
The mean (±SD) of initial systolic blood 
pressure (SBP) was 136.0(±19.8) mm Hg 
ranging from 70 to 240 mm Hg and the            
mean (± SD) diastolic blood pressure             
(DBP) was 80.6 (±9.8) mm Hg ranging from 
50 to  120 mm Hg.   In this study, out  of  1077   
 
Patients recruited,  456 (42.3 %) had SBP ≥ 
140 mm Hg and total of 324 (30.1 %) had 
DBP ≥  80 mm Hg.  
For the patients who were on 
antihypertensive medications, 254 (23.6 %) of 
them were on monotherapy and 311 (28.9 %), 
179 (16.6 %), and 198 (18.3 %) respectively 
received two, three and more than three 
antihypertensive agents. Most diabetic patients 
with hypertension require combination therapy 
to achieve optimal blood pressure goals. (Amos 
et al., 1997; Zimmet,1995). In United Kingdom 
Prospective Diabetes Study (UKPDS), over           
60 % of participants in the more intensively 
treated group received 2 or more medications, 
and 29 % received 3 or more medications to 
achieve a mean blood pressure of 144/82 mm 
Hg (UKPDS ,1998).  
According to antihypertension patterns 
in type 2 diabetes patients, majority of patients  
942 (94.4 %) were on various antihypertensive 
drugs, out of them 872 (87.4 %) were on 
angiotensin converting enzyme inhibitors 
(ACEIs)/ angiotensin receptor blockers 
(ARBs)  either alone or in combination with 
other antihypertensive drugs. ACEIs and ARBs 
are the agents of choice for diabetes mellitus 
with hypertension according to the practice 
guidelines (American Diabetes Association, 
2002; Vijan and Hayward, 2003).  
Table II Antihypertension pattern in type 2 diabetes patients 
 
Variable Frequency (%) n=998 
No medication  56 (5.6 %) 
ACEIs 184(18.4 %) 
CCBs 70 (7.0 %) 
ACEIs and CCBs   168(16.8 %) 
ARBs and CCBs   143(14.3 %) 
ACEIs,  β-Blockers and CCBs    95(9.5 %) 
ARBs, β-Blockers  and CCBs   84(8.4 %) 
ARBs, β-Blockers , CCBs and  Diuretics  95(9.5 %) 
ARBs, α - blockers ,  β-Blockers  and CCBs 103(10.3 %) 
Total 998(100 %) 
 
 
ACEIs  = angiotensin-converting enzyme inhibitors,  
 CCBs  = calcium channel blockers,  
ARBs   = angiotensin II receptor blockers 
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A number of 184 (18.4 %) were taking 
ACEIs as monotherapy, 168 (16.8 %) were on 
combination of ACEIs and CCBs (calcium 
channel blockers), while 143 (14.3 %) were on 
combination of ARBs and CCBs. Another           
95 (9.5 %) were on combination of ACEIs, 
CCBs and  β-blockers (Table II)   
Reducing  SBP to less than 130 mm Hg 
and DBP to less than 80 mm Hg in patients 
with diabetes has been shown to reduce 
diabetes-related mortality, microvascular 
complications, stroke, and all diabetes end 
points (American Diabetes Association, 2002). 
As for hypertension control, by performing 
cross-tabulation between antihypertension 
medication patterns and blood pressure target 
in type 2 diabetes patients (Table III) the 
majority of patients 601 (55.8 %) had achieved 
BP targets ≤ 130/80 mmHg, out of those               
122 (20.3 %) were on ACEIs as monotherapy,           
87 (14.5 %) were on combination of ACEIs 
and CCBs, while 476 (44.2 %) had not 
achieved BP targets (over 130/80 mmHg), out 
of these 69 (14.5 %) were on combination of 
ARBs, CCBs, α-blockers and β-blockers.  
Multiple clinical trials have been 
conducted to compare various antihypertensive 
agents to placebo or to other active 
comparators.   In   The    Antihypertensive and  
 
Lipid-Lowering Treatment to Prevent Heart 
Attack Trial (ALLHAT), approximately 60 % 
of participants were controlled to SBP of less 
than 140 mm Hg (ALLHAT, 2002). In the 
subgroup of participants with diabetes, the 
mean SBP ranged from 135 to 137 mmHg 
across the treatment groups despite the use of 
2 medications on average (Whelton et al., 2005). 
In The Anglo-Scandinavian Cardiac Outcomes 
Trial (ASCOT), 53 % of participants reached 
both their systolic and diastolic blood-pressure 
targets, but only 32 % of patients with diabetes 
reached their intensive targets of SBP less than 
130 and DBP less than 80 mm Hg (Dahlof et 
al., 2005).  
This study showed that 13.0 % of 
patients who achieved target were taken triple 
medication (ACEIs,CCBs, and β Blockers; 
ARBs,CCBs, and β- blockers). No study has 
examined the effectiveness of triple drug 
therapy with a  β-blockers, ACEIs or ARBs  
and CCBs either in patients with or without 
diabetes. Nevertheless, it is clear from the 
ALLHAT, ASCOT and UKPDS experiences 
that the majority of patients with                 
diabetes and high BP will need three or                 
more medications to achieve SBP less than    
130 mm Hg (UKPDS, 1998; ALLHAT, 2002, 
Dahlof et al., 2005). 
Table III.  Association between blood pressure target and antihypertension medication pattern in 
type 2 diabetes patients 
 
Variables Target ≤ 130/80 
mmHg 
Non target 
>130/80mmHg 
No Medication Used 114 (19.0%) 21 (4.4%) 
ACEIs 122 (20.3%) 62 (13.0%) 
CCBs 36 (6.0%) 34 (7.1%) 
ACEIs and CCBs   87(14.5%) 81 (17.0%) 
ARBs and CCBs   83 (13.8%) 60 (12.6%) 
ACEIs, CCBs and  β-Blockers 43 (7.2%) 52 (10.9%) 
ARBs, CCBs   and  β-Blockers 35 (5.8%) 49 (10.3%) 
ACEIs, CCBs , β-Blockers and Diuretics 47(7.8%) 48 (10.1%) 
ARBs, CCBs,  α.-blockers and β-Blockers 34 (5.7%) 69 (14.5%) 
Total 601 (100%) 476 (100%) 
 
 ACEIs  = angiotensin-converting enzyme inhibitors,  
 CCBs  = calcium channel blockers,  
ARBs   = angiotensin II receptor blockers 
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As clearly stated by recent guidelines 
most patients with diabetes will require two or 
more antihypertensive therapies from different 
classes with complementary mechanisms of 
action to control their blood pressure. Thiazide 
diuretics, β-blockers, or CCBs can be added to 
ACEIs or ARBs treatment to achieve target 
blood pressure. Combining an ACEIs or an 
ARBs with a thiazide diuretic may be 
particularly effective, as such combinations 
provide additive reductions in BP compared 
with individual monotherapies, and counteract 
many of the adverse events that may be 
associated with the use of high doses of 
thiazide diuretics (Klauser et al., 1991; Kjeldsen 
et al., 2005), and abolish any inter racial 
differences in the response to ACEIs or ARBs 
monotherapy (Douglas et al., 2003). Certain            
β-blockers may be preferred as add-on 
antihypertensive medications for patients with 
diabetes because of their glycaemic and 
metabolic effects. Carvedilol, a nonselective           
β-blockers, has more favorable effects on 
haemoglobin A1c (HbA1c) levels, insulin 
sensitivity, total cholesterol levels, and 
triglyceride levels than metoprolol in patients 
with type 2 diabetes mellitus and hypertension 
already receiving an ACEIs or ARBs despite 
similar effects on blood pressure (Bakris et al., 
2004).  
Some studies showed that only a very 
small percentage of patients were optimally 
managed (Burt et al.,1991; Hyman and Pavlik, 
2001). Different  results were observed in  our 
study in which the target BP was not achieved 
in the 476 (44.2 %) of patients with              
type 2 diabetes mellitus  and hypertension.            
The poor control of hypertension                      
may result from the inadequate use of 
antihypertensive agents, may be come            
from    age,   and   duration   of  hypertension.  
Although in most of the antihypertensive 
intervention studies two,  three or even more 
drugs of antihypertensive classes were used, the 
necessary target  values were not reached in the 
majority of studies.  
There were several limitations to this 
study. The control of BP may be affected by 
the patients’ adherence, life style and other risk 
factors, and this study analyzed was based on a 
clinical population, thus data from other 
centers are required to determine whether the 
finding in this study can be generalized to 
diabetes care setting.  
 
Conclusion 
Hypertension is extremely common in 
patients with type 2 diabetes. The highest 
percentage of patients had hypertension treated 
with combined antihypertensive drug therapy.  
A number of patients was not  achieved blood 
pressure goals of ≤130/80 mm Hg.  There is 
an urgent  need to educate both patients and 
health care providers of importance of 
achieving target of blood pressure treatment in 
order to reduce morbidity and mortality in 
diabetes mellitus patients. 
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